Cresilon, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-266/26/26 | Amended | $28,999,199 | $24,002,199 | Debt Only | 06c | SEC linkSEC |
| 2026-04-294/29/26 | New | $4,997,000 | $4,997,000 | Debt Only | 06b | SEC linkSEC |
| 2025-12-0812/8/25 | New | $6,683,401 | $6,683,401 | Equity Only | 06c | SEC linkSEC |
| 2025-09-059/5/25 | New | $17,172,969 | Unknown | Other | SEC linkSEC | |
| 2025-01-311/31/25 | New | $24,999,967 | $24,999,967 | Equity Only | 06c | SEC linkSEC |
| 2024-10-0810/8/24 | New | $17,243,350 | $17,243,350 | Equity Only | 06b | SEC linkSEC |
| 2022-10-1810/18/22 | New | $24,999,999 | $24,999,999 | Equity Only | 06c | SEC linkSEC |
| 2021-02-162/16/21 | New | $24,464,276 | $24,464,276 | Equity Only | 06b | SEC linkSEC |
| 2018-01-121/12/18 | New | $13,338,000 | $13,338,000 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Joseph Landolina | Director, Executive |
| Scott Levine | Executive |
| Isaac Miller | Director |
Industry: Biotechnology (See others in industry)
Address:
122 18 Th Street
Brooklyn, NY, 11215
Phone: (347) 435-2226
Brooklyn, NY, 11215
Phone: (347) 435-2226